Abstract
Previous studies show that X-ray cross-complementing group 1 (XRCC 1) Arg399Gln may result in variations in repair efficiency of DNA damage, and this repair deficit may eventually cause individual susceptibility to glioma. However, published data regarding the association between XRCC 1 Arg399Gln polymorphism and glioma risk was contradictory. The aim of this study was to derive a more precise estimation of the association of XRCC 1 Arg399Gln polymorphism with glioma risk by performing a meta-analysis of eligible studies. Odds ratios (ORs) and 95 % confidence intervals (95 %CIs) were used to assess the strength of the association. We performed a meta-analysis of eleven published studies that included 2,808 glioma cases and 3,114 controls. Overall, there was a significant association between XRCC1 Arg399Gln polymorphism and glioma risk in two genetic models (for ArgGln vs ArgArg: OR = 1.30, 95 % CI 1.01–1.68; for GlnGln/ArgGln vs ArgArg: OR = 1.28, 95 % CI 1.01–1.62). In the stratified analysis by ethnicity, the XRCC1 Arg399Gln polymorphism had a higher risk of glioma development among Asians (for Gln vs Arg: OR = 1.34, 95 % CI 1.12–1.61; for GlnGln vs ArgArg: OR = 1.72, 95 % CI 1.18–2.51; for ArgGln vs ArgArg: OR = 1.31, 95 % CI 1.01–1.71; for GlnGln/ArgGln vs ArgArg: OR = 1.41, 95 % CI 1.10–1.80; for GlnGln vs ArgArg/ArgGln: OR = 1.48, 95 % CI 1.05–2.09)., but not among Caucasians. In conclusion, the results suggest that the XRCC 1 Arg399Gln polymorphism may contribute to the susceptibility of glioma in Asians.
Similar content being viewed by others
References
Ricard D, Idbaih A, Ducray F et al (2012) Primary brain tumours in adults. Lancet 379:1984–1996
Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359:492–507
Schwartzbaum JA, Fisher JL, Aldape KD et al (2006) Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2:494–503; quiz 491 p following 516
Tewari R, Choudhury SR, Mehta VS et al (2012) TNFalpha regulates the localization of CD40 in lipid rafts of glioma cells. Mol Biol Rep 39:8695–8699
Shete S, Hosking FJ, Robertson LB et al (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41:899–904
Gu J, Liu Y, Kyritsis AP et al (2009) Molecular epidemiology of primary brain tumors. Neurotherapeutics 6:427–435
Caldecott KW (2003) XRCC1 and DNA strand break repair. DNA Repair (Amst) 2:955–969
Horton JK, Watson M, Stefanick DF et al (2008) XRCC1 and DNA polymerase beta in cellular protection against cytotoxic DNA single-strand breaks. Cell Res 18:48–63
Goode EL, Ulrich CM, Potter JD (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11:1513–1530
Thompson LH, West MG (2000) XRCC1 keeps DNA from getting stranded. Mutat Res 459:1–18
Ginsberg G, Angle K, Guyton K et al (2011) Polymorphism in the DNA repair enzyme XRCC1: utility of current database and implications for human health risk assessment. Mutat Res 727:1–15
Hu Z, Ma H, Chen F et al (2005) XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case–control studies. Cancer Epidemiol Biomarkers Prev 14:1810–1818
Dai L, Duan F, Wang P et al (2012) XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case–control studies. Mol Biol Rep 39:9535–9547
Berhane N, Sobti RC, Mahdi SA (2012) DNA repair genes polymorphism (XPG and XRCC1) and association of prostate cancer in a north Indian population. Mol Biol Rep 39:2471–2479
Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101–129
Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
Cengiz SL, Acar H, Inan Z et al (2008) Deoxy-ribonucleic acid repair genes XRCC1 and XPD polymorphisms and brain tumor risk. Neurosciences (Riyadh) 13:227–232
Custodio AC, Almeida LO, Pinto GR et al (2011) Analysis of the polymorphisms XRCC1Arg194Trp and XRCC1Arg399Gln in gliomas. Genet Mol Res 10:1120–1129
Felini MJ, Olshan AF, Schroeder JC et al (2007) DNA repair polymorphisms XRCC1 and MGMT and risk of adult gliomas. Neuroepidemiology 29:55–58
Hu XB, Feng Z, Fan YC et al (2011) Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to glioma. Asian Pac J Cancer Prev 12:2981–2984
Kiuru A, Lindholm C, Heinavaara S et al (2008) XRCC1 and XRCC3 variants and risk of glioma and meningioma. J Neurooncol 88:135–142
Liu JM, Sun H, Huang LW et al (2011) Relationship between XRCC 1 polymorphisms and adult gliomas. Mod Prev Med 38:3340–3341
Liu Y, Scheurer ME, El-Zein R et al (2009) Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev 18:204–214
Rajaraman P, Hutchinson A, Wichner S et al (2010) DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol 12:37–48
Wang LE, Bondy ML, Shen H et al (2004) Polymorphisms of DNA repair genes and risk of glioma. Cancer Res 64:5560–5563
Yosunkaya E, Kucukyuruk B, Onaran I et al (2010) Glioma risk associates with polymorphisms of DNA repair genes, XRCC1 and PARP1. Br J Neurosurg 24:561–565
Zhou LQ, Ma Z, Shi XF et al (2011) Polymorphisms of DNA repair gene XRCC1 and risk of glioma: a case–control study in Southern China. Asian Pac J Cancer Prev 12:2547–2550
Sanai N, Alvarez-Buylla A, Berger MS (2005) Neural stem cells and the origin of gliomas. N Engl J Med 353:811–822
Liu Y, Shete S, Hosking F et al (2010) Genetic advances in glioma: susceptibility genes and networks. Curr Opin Genet Dev 20:239–244
Huang Y, Li L, Yu L (2009) XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis. Mutagenesis 24:331–339
Liu F, Li B, Wei Y et al (2011) XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis. Liver Int 31:802–809
Butkiewicz D, Rusin M, Sikora B et al (2011) An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer. Mol Biol Rep 38:5231–5241
Chen B, Zhou Y, Yang P et al (2012) Polymorphisms of XRCC1 and gastric cancer susceptibility: a meta-analysis. Mol Biol Rep 39:1305–1313
Wang B, Wang D, Huang G et al (2010) XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis. Int J Colorectal Dis 25:313–321
Conflict of interests
The authors have declared that no competing interests exist.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wei, X., Chen, D. & Lv, T. A functional polymorphism in XRCC1 is associated with glioma risk: evidence from a meta-analysis. Mol Biol Rep 40, 567–572 (2013). https://doi.org/10.1007/s11033-012-2093-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-012-2093-y